16-83899145-A-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_012213.3(MLYCD):āc.1A>Cā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000176 in 1,138,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_012213.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLYCD | NM_012213.3 | c.1A>C | p.Met1? | start_lost | 1/5 | ENST00000262430.6 | NP_036345.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLYCD | ENST00000262430.6 | c.1A>C | p.Met1? | start_lost | 1/5 | 1 | NM_012213.3 | ENSP00000262430 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000669 AC: 1AN: 149568Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000101 AC: 1AN: 989212Hom.: 0 Cov.: 28 AF XY: 0.00000212 AC XY: 1AN XY: 472012
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149676Hom.: 0 Cov.: 33 AF XY: 0.0000137 AC XY: 1AN XY: 73052
ClinVar
Submissions by phenotype
Deficiency of malonyl-CoA decarboxylase Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MLYCD protein in which other variant(s) (p.Gly3Asp) have been observed in individuals with MLYCD-related conditions (PMID: 12955715). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Disruption of the initiator codon has been observed in individual(s) with biochemical features of MLYCD-related disorders (PMID: 32602666; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the MLYCD mRNA. The next in-frame methionine is located at codon 40. - |
MLYCD-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 01, 2023 | The MLYCD c.1A>C variant is predicted to disrupt the translation initiation site (Start loss). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Other variants disrupting the ATG start codon in MLYCD have been reported to be causative for malonyl-CoA decarboxylase deficiency (c.2T>A in Polinati et al. 2015. PubMed ID: 24613099; c.1A>G in Lee et al. 2020. PubMed ID: 32602666 ). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.